144 related articles for article (PubMed ID: 26226125)
1. Are obesity and metabolic syndrome associated with plasma adropin levels in children?
Kocaoglu C; Buyukinan M; Erdem SS; Ozel A
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1293-7. PubMed ID: 26226125
[TBL] [Abstract][Full Text] [Related]
2. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relationship between serum adropin levels and blood pressure in obese children.
Altincik A; Sayin O
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1095-100. PubMed ID: 26030787
[TBL] [Abstract][Full Text] [Related]
4. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.
Butler AA; Tam CS; Stanhope KL; Wolfe BM; Ali MR; O'Keeffe M; St-Onge MP; Ravussin E; Havel PJ
J Clin Endocrinol Metab; 2012 Oct; 97(10):3783-91. PubMed ID: 22872690
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome in obese Thai children and adolescents.
Iamopas O; Chongviriyaphan N; Suthutvoravut U
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
[TBL] [Abstract][Full Text] [Related]
6. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
Reinehr T; Roth CL
J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
[TBL] [Abstract][Full Text] [Related]
7. Role of serum adropin measurement in the assessment of insulin resistance in obesity.
Erman H; Ozdemir A; Sitar ME; Cetin SI; Boyuk B
J Investig Med; 2021 Oct; 69(7):1318-1323. PubMed ID: 34016737
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty.
Tobisch B; Blatniczky L; Barkai L
Pediatr Obes; 2015 Feb; 10(1):37-44. PubMed ID: 24227418
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects.
Yosaee S; Khodadost M; Esteghamati A; Speakman JR; Shidfar F; Nazari MN; Bitarafan V; Djafarian K
Am J Mens Health; 2017 Mar; 11(2):426-434. PubMed ID: 27550773
[TBL] [Abstract][Full Text] [Related]
10. Adropin and glucagon-like peptide-2 are associated with glucose metabolism in obese children.
Chen RM; Yuan X; Ouyang Q; Lin XQ; Ai ZZ; Zhang Y; Yang XH
World J Pediatr; 2019 Dec; 15(6):565-571. PubMed ID: 31598832
[TBL] [Abstract][Full Text] [Related]
11. Serum adropin levels in psoriasis vulgaris and its relation with metabolic parameters.
Korkmaz S; Sayılan Özgün G
Turk J Med Sci; 2019 Feb; 49(1):110-115. PubMed ID: 30762319
[TBL] [Abstract][Full Text] [Related]
12. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
13. Circulating adropin levels in patients with endometrium cancer.
Nergiz S; Altinkaya SO; Kurt Ömürlü İ; Yuksel H; Küçük M; Demircan Sezer S
Gynecol Endocrinol; 2015; 31(9):730-5. PubMed ID: 26172926
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
15. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
16. Relationship between obesity and metabolic syndrome among Argentinean elementary school children.
Hirschler V; Oestreicher K; Maccallini G; Aranda C
Clin Biochem; 2010 Mar; 43(4-5):435-41. PubMed ID: 19913002
[TBL] [Abstract][Full Text] [Related]
17. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity.
Anık A; Çatlı G; Abacı A; Küme T; Bober E
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):623-8. PubMed ID: 24825087
[TBL] [Abstract][Full Text] [Related]
18. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
[TBL] [Abstract][Full Text] [Related]
19. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population].
López-Capapé M; López-Bermejo A; Alonso Blanco M; Lara Orejas E; Corbatón Blasco J; Barrio Castellanos R
An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541
[TBL] [Abstract][Full Text] [Related]
20. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
Ragab A; Abousamra NK; Higazy A; Saleh O
Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
